These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Efficacy and safety of aztreonam in the treatment of patients with renal failure. Sion ML, Pyrpasopoulos M, Nicolaidis P, Papagianni C, Tsurutsoglu G. Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477 [Abstract] [Full Text] [Related]
27. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria. Scully BE, Neu HC. Arch Intern Med; 1984 Jan; 144(1):57-62. PubMed ID: 6419690 [Abstract] [Full Text] [Related]
29. Evaluation of aztreonam in the treatment of severe bacterial infections. Romero-Vivas J, Rodríguez-Créixems M, Bouza E, Hellín T, Guerrero A, Martínez-Beltrán J, García de la Torre M. Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832 [Abstract] [Full Text] [Related]
32. Carbenicillin therapy of gram-negative bacilli infections. Bodey GP, Rodriguez V, Luce JK. Am J Med Sci; 1969 Jun; 257(6):408-14. PubMed ID: 4893148 [No Abstract] [Full Text] [Related]
33. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections. Tsouroutsoglou W, Sion ML, Stathopoulos GA, Kapoulas S, El-Messidi M, Paradelis AG. Methods Find Exp Clin Pharmacol; 1983 Jun; 5(6):385-90. PubMed ID: 6684719 [Abstract] [Full Text] [Related]
34. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients. Issell BF, Keating MJ, Valdivieso M, Bodey GP. Am J Med Sci; 1979 Jun; 277(3):311-8. PubMed ID: 256433 [Abstract] [Full Text] [Related]
35. Aztreonam therapy for serious gram-negative infections in children. Stutman HR, Chartrand SA, Tolentino T, Friedhoff L, Marks MI. Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490 [Abstract] [Full Text] [Related]